The Clorox Company (NYSE:CLX) Shares Purchased by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC raised its holdings in The Clorox Company (NYSE:CLX) by 5.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,084 shares of the company’s stock after purchasing an additional 760 shares during the period. Concurrent Investment Advisors LLC’s holdings in Clorox were worth $2,620,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CLX. Nordea Investment Management AB raised its stake in Clorox by 4.5% during the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after buying an additional 426 shares in the last quarter. Central Pacific Bank Trust Division bought a new stake in shares of Clorox in the 1st quarter valued at approximately $88,000. Texas Permanent School Fund Corp raised its position in shares of Clorox by 1.8% during the 1st quarter. Texas Permanent School Fund Corp now owns 25,636 shares of the company’s stock valued at $3,925,000 after acquiring an additional 455 shares in the last quarter. Advisory Services Network LLC lifted its stake in Clorox by 5.2% during the first quarter. Advisory Services Network LLC now owns 20,515 shares of the company’s stock worth $3,141,000 after purchasing an additional 1,008 shares during the last quarter. Finally, Empirical Finance LLC boosted its holdings in Clorox by 3.5% in the first quarter. Empirical Finance LLC now owns 4,457 shares of the company’s stock worth $682,000 after purchasing an additional 152 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX opened at $162.85 on Friday. The firm has a market capitalization of $20.16 billion, a PE ratio of 56.74, a P/E/G ratio of 3.02 and a beta of 0.41. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a 50-day moving average price of $161.89 and a 200 day moving average price of $146.58. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the firm posted $0.49 earnings per share. The business’s revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts anticipate that The Clorox Company will post 6.81 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 170.04%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CLX. Citigroup raised their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and lifted their target price for the company from $155.00 to $170.00 in a research note on Wednesday. JPMorgan Chase & Co. upped their target price on Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a report on Monday. Finally, Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research note on Monday, October 14th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $155.00.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.57% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.